Stifel Reiterates Buy Rating on Amazon.com (AMZN), Sees Deal Expanding Co's Reach and Services of Amazon Care

Amazon (AMZN) Lacks Short-Term Catalysts - Mizuho

Mizuho Securities analyst James Lee cut the price target on Amazon (NASDAQ: AMZN) shares from $198 to $155 on Thursday, maintaining the firm's Buy rating on the stock.

Lee explained that recent investor calls on advertising and cloud computing indicate downside to consensus estimates,... More

Cowen has 'a thesis that many primary-care VBC companies could be acquired by health insurers over the next several year'

Cowen analyst Gary Taylor comments "We have a thesis that many primary-care VBC companies could be acquired by health insurers over the next several years as they seek the benefits of vertical integration and seek to compete with bellwether UNHs OptumCare division. However, despite its recent Iora Medicare Advantage... More

Evercore ISI Reiterates Outperform Rating on Amazon.com (AMZN), Says Deal is 'strategically sensible'

Evercore ISI analyst Mark Mahaney reiterated an Outperform rating and $180.00 price target on Amazon.com (NASDAQ: AMZN).

The analyst comments "As a quick first pass, we view Amazons announced acquisition of One Medical (ONEM) for $3.9B (all cash) as strategically... More

Stifel Reiterates Buy Rating on 1Life Healthcare Inc. (ONEM)

Stifel analyst Craig Jones reiterated a Buy rating and {REMOVEPT} price target on 1Life Healthcare Inc. (NASDAQ: ONEM)

The analyst offers quick thoughts on the acquisition "ONEM has obviously been in play, which implies others have evaluated the opportunity. As summarized in our previous... More

Citi Not Shocked 1Life Healthcare Inc. (ONEM) Was Acquired, is Surprised Amazon (AMZN) Won, Expects Teladoc (TDOC) to Trade Lower

Citi analyst Ralph Giacobbe reiterated a Neutral rating and $14.00 price target on 1Life Healthcare Inc. (NASDAQ: ONEM).

The analyst comments "While we are not surprised that ONEM is being acquired, we are a bit surprised that AMZN has emerged as the winning bidder. The commercial strategy makes a lot of sense to usthe elegant blending of virtual and... More

Evercore ISI on Amazon (AMZN) Acquiring 1Life Healthcare Inc. (ONEM): 'Wow!', Sees Deal as Modest Negative For CVS (CVS)

Evercore ISI analyst Elizabeth Anderson reiterated an In Line rating and $12.00 price target on 1Life Healthcare Inc. (NASDAQ: ONEM).

The analyst comments "Wow! With our healthcare lens, we were overly-focused here about the potential take out potential of ONEM by managed care. Todays announcement expands Amazons footprint in healthcare and adds physical clinics as well as payer and hospital system relationships to Amazons current telehealth capabilities as well as providing Amazon a well-known customer brand in the space. We would expect... More

Amazon's (AMZN) electric delivery vehicles from Rivian (RIVN) roll out across the U.S.

Amazon and Rivian plan to bring thousands of custom electric delivery vehicles to more than 100 cities by the end of this year, and 100,000 across the U.S. by 2030.

Customers across the U.S. will begin to see custom electric delivery vehicles from Rivian delivering their Amazon packages, with the electric vehicles hitting the road in Baltimore, Chicago, Dallas, Kansas City, Nashville, Phoenix, San Diego, Seattle, and St. Louis, among other cities. This rollout is just the beginning of what is expected to be thousands of Amazons custom electric delivery vehicles in more than 100... More

Teladoc (TDOC) Weakness Tied to Amazon's Deal for 1Life Healthcare

Teladoc (NYSE: TDOC) Weakness Tied to Amazon's Deal for 1Life Healthcare

Pre-Open Movers: One Medical Surges on Amazon Takeover, Carnival Falls on Stock Offering

Pre-Open Stock Movers:

One Medical (NASDAQ: ONEM) 67% HIGHER; Amazon (NASDAQ: AMZN) will acquire One Medical for $18 per share.

Verve Therapeutics, Inc. (Nasdaq: VERV) 13% LOWER; announced that it has commenced an underwritten public offering of $200.0 million of shares of its common stock

Carnival Corporation (NYSE:... More

Amazon (AMZN) to Buy One Medical (ONEM) in $3.9 Billion All Cash Deal

Amazon (NASDAQ: AMZN) has announced today it will acquire One Medical (NASDAQ: ONEM) for $18 per share.

One Medical is described as a human-centered, technology-powered national primary care organization on a mission to make quality care more affordable, accessible, and enjoyable... More

Amazon strikes $3.5 billion deal for One Medical in long march into U.S. healthcare

By Manas Mishra and Jeffrey Dastin

(Reuters) -Amazon.com Inc on Thursday agreed to buy primary care provider One Medical for $3.49 billion, expanding the e-commerce giant's virtual healthcare and adding brick-and-mortar doctors' offices for the first time.

The all-cash deal would combine two relatively small players as Amazon continues a years-long march into U.S. healthcare, seeking to grow at a faster pace.

The online retailer first piloted virtual care visits for its own staff in Seattle in 2019 before offering services to other employers under the Amazon Care brand. It likewise bought online pharmacy PillPack in 2018, underpinning... More

Amazon (AMZN) to Acquire One Medical (ONEM) for $18 Per Share

Today Amazon (NASDAQ: AMZN) and One Medical (NASDAQ: ONEM) announced that they have entered into a definitive merger agreement under which Amazon will acquire One Medical. One Medical is a human-centered, technology-powered national primary care organization on a mission to make quality care more affordable, accessible, and enjoyable through a seamless combination of in-person, digital, and virtual care services that are convenient to where people work, shop, and live.

We think health care is high on the list of experiences that need reinvention. Booking... More

Amazon.com (AMZN) PT Lowered to $155 at Deutsche Bank

Deutsche Bank analyst Leo Horowitz lowered the price target on Amazon.com (NASDAQ: AMZN) to $155.00 (from $174.00) while maintaining a Buy rating.... More

Amazon.com (AMZN) PT Lowered to $155 at Mizuho Securities

Mizuho Securities analyst James Lee lowered the price target on Amazon.com (NASDAQ: AMZN) to $155.00 (from $197.50) while maintaining a Buy rating.... More

Amazon (AMZN) Remains Top Pick at JPMorgan

Amazon (NASDAQ: AMZN) Remains Top Pick at JPMorgan.

Analyst Doug Anmuth comments "AMZN shares have traded down -26% YTD, underperforming the SPX down -17% YTD, as concerns have mounted around slower consumer spending & overall e-commerce. We trimmed estimates considering e-comm faces macro pressures... More

Active options: AMZN NVDA TSLA NFLX AMD F GOOG META MARA COIN

Active options: AMZN NVDA TSLA NFLX AMD F GOOG META MARA COIN

BofA Cuts Amazon (AMZN) Price Target On FX Pressure

Ahead of Amazon's (NASDAQ: AMZN) latest earnings release on July 28, analysts at BofA and Jefferies cut their price targets on the stock.

BofA analyst Justin Post reiterated a Buy rating but lowered the firm's price target from $188 to $168, telling clients in a research note that they are lowering 2022 and 2023 estimates to reflect recent FX pressure and the BofA outlook for a mild fourth quarter recession.

"Ex-FX, we expect meet/beat 2Q, as BAC aggregated credit and debit card data points to 2pts of... More

UPDATE: Amazon (AMZN) PT Lowered to $168 at BofA, Remains Bullish on 'Depressed Profits and Valuation'

(Updated - July 20, 2022 7:49 AM EDT)

BofA Securities analyst Justin Post lowered estimates and the price target on Amazon.com (NASDAQ: AMZN) to $168.00 (from $188.00) while maintaining a Buy rating ahead of earnings. While the consumer outlook is cloudy, they remain positive on depressed... More

UPDATE: Amazon.com (AMZN) PT Lowered to $150 at Jefferies, Remains Franchise Picks

(Updated - July 20, 2022 4:29 AM EDT)

Jefferies analyst Brent Thill lowered the price target on Amazon.com (NASDAQ: AMZN) to $150.00 (from $163.00) while maintaining a Buy rating.

The analyst comments "We see AMZN returning to outperformance in 2H22 as top-line accelerates and profit... More